Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
| Revenue (Most Recent Fiscal Year) | $20.63B |
| Net Income (Most Recent Fiscal Year) | $582.08M |
| PE Ratio (Current Year Earnings Estimate) | 13.51 |
| PE Ratio (Trailing 12 Months) | 16.22 |
| PEG Ratio (Long Term Growth Estimate) | 1.41 |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.98 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 5.83 |
| Pre-Tax Margin (Trailing 12 Months) | 5.91% |
| Net Margin (Trailing 12 Months) | 3.18% |
| Return on Equity (Trailing 12 Months) | 6.25% |
| Return on Assets (Trailing 12 Months) | 2.88% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.46 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.03 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.40 |
| Inventory Turnover (Trailing 12 Months) | 6.93 |
| Book Value per Share (Most Recent Fiscal Quarter) | $29.08 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.44 |
| Earnings per Share (Most Recent Fiscal Year) | $1.66 |
| Diluted Earnings per Share (Trailing 12 Months) | $1.12 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | -- |
| Free Float | -- |
| Market Capitalization | -- |
| Average Volume (Last 20 Days) | 0.46M |
| Beta (Past 60 Months) | 0.85 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 8.37% |
| Annual Dividend (Based on Last Quarter) | $0.44 |
| Dividend Yield (Based on Last Quarter) | 1.56% |